Immunology for allergic disease and their therapy

Image

Immunotherapy is a preventive treatment for allergic drug reactions, such as grass pollen, house dust mites, and bee venom. Immunotherapy requires the administration of increasingly increasing doses of the drug or allergen to which the person is allergic. Allergen immunotherapy, also known as allergy shots, for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy, is a type of long-term therapy that reduces symptoms. Allergy shots reduce allergy sensitivity and sometimes contribute to long-lasting relief of allergy symptoms, even after termination of care. For certain patients, this makes it a cost-effective, beneficial path to care. Allergy tablets are a type of sublingual immunotherapy (SLIT) which provides a shot-free way of treating certain allergies. Like injections, by helping the body develop resistance to the effects of an allergen, tablets lessen symptoms. Tablets, unlike shots, only treat one form of allergen and do not prevent new allergies and asthma from emerging. To treat allergies, FDA-approved SLIT tablets are available. Tiny amounts of the allergen are used in each injection so that your body develops immunity to it over time. The approach works just like taking a vaccine, where new antibodies are formed by your body to fight invasive substances. In addition to allergens, allergy shots often enhance the way other immune system cells and substances work. Effective immunotherapy gradually helps the body battle off allergens and decrease adverse effects. There are two phases for allergy shots work: Step Build-up. This includes getting injections about one or two times a week with rising levels of the allergens. The period of this process depends on the frequency of injections, but usually varies from three to six months. Phase of maintenance. When the effective dosage is reached, this starts. The effective maintenance dose is based on your sensitivity level to the allergen and your reaction to the build-up process.

Media Contact:

Allison Grey

Journal Manager

Journal of Clinical chemistry and Laboratory Medicine

Email: clinchem@longdomjournal.org